微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 7.82% | -4.87% | 45.08% | 40/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.39% | -10.61% | 71.11% | 32/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.15% | -9.74% | -69.91% | 26/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 10.47% | -9.35% | 27.37% | 29/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.22% | -12.46% | 36.32% | 36/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 6.03% | -9.6% | 72.78% | 29/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.49% | -9.11% | -69.78% | 27/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 11.55% | 8.96% | 23% | 33/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 9.39% | 5.62% | 40.78% | 35/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.67% | 26.81% | 73.7% | 30/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.84% | 17.79% | -63.77% | 20/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 10.6% | 18.04% | 19.24% | 42/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 8.89% | 1.95% | 69.01% | 44/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.26% | -5.4% | 61.35% | 52/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.26% | 22.56% | -63.7% | 39/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 8.98% | 7.93% | 2.98% | 64/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 8.72% | 12.37% | 56.83% | 43/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.56% | 9.23% | 109.02% | 45/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.66% | -14.74% | -68.03% | 38/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 8.32% | 4.26% | 7.22% | 67/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 7.76% | -7.95% | 52.46% | 48/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 5.09% | -1.17% | 63.14% | 48/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.12% | 3.65% | -60.9% | 36/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 7.98% | 1.01% | -5.34% | 67/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 8.43% | -73.62% | 63.69% | 38/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 5.15% | -1.53% | 71.1% | 39/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.01% | -13.93% | -61.9% | 30/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 7.9% | 21.54% | -75.27% | 67/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 31.95% | 313.86% | 510.9% | 2/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 5.23% | 11.51% | 49.56% | 40/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.5% | 5.11% | -46.2% | 17/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 6.5% | -18.75% | -15.8% | 74/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 7.72% | -19.25% | 64.61% | 36/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 4.69% | -25.65% | 40.97% | 42/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 3.33% | -17.09% | -58.41% | 24/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 8% | 5.26% | -16.32% | 58/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 9.56% | 32.96% | 51.55% | 29/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 6.31% | 41.66% | 57.19% | 28/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 4.01% | 38.38% | -47.2% | 18/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |